Morgan Stanley Finance Issues Jump Notes Linked to AMD, Meta, and Microsoft Performance Through 2029

Structured Investment Architecture and Underlier Selection

Morgan Stanley Finance LLC structured the Jump Notes to track the performance of three major technology company equities: Advanced Micro Devices Inc., Meta Platforms Inc. Class A common stock, and Microsoft Corporation common stock. The use of multiple underliers creates a specific risk profile whereby investors are exposed to the worst-performing asset among the three, rather than benefiting from diversification. This worst-performing underlier methodology means that strong performance by two of the three stocks cannot offset weakness in the third, concentrating downside exposure on the most underperforming component of the basket.

The notes are structured as unsecured obligations of Morgan Stanley Finance LLC and are fully and unconditionally guaranteed by Morgan Stanley, the parent company. However, the filing emphasizes that the notes are not secured obligations and investors will not have any security interest in or access to the underlying reference assets themselves. This guarantee extends only to Morgan Stanley's creditworthiness; if Morgan Stanley defaults on its obligations, investors could lose some or all of their investment.

Pricing, Valuation, and Cost Structure

The stated principal amount for each note is $1,000, representing the price at which investors purchase the notes. However, the disclosure indicates that the estimated value on the pricing date is approximately $983.90 per note, or within $45.00 of that estimate. This approximately $16 discount reflects costs associated with issuing, selling, structuring, and hedging the notes, which are borne by investors at the time of purchase. The difference between issue price and estimated value is material and represents the cost embedded in the security from inception.

Morgan Stanley & Co., acting as the agent, plans to sell the notes exclusively to investors in fee-based advisory accounts. The agent's commission structure includes potential structuring fees of up to $6.25 per note paid to selected dealers and their financial advisors. Additionally, the filing discloses that Morgan Stanley & Co. may pay a third-party data analytics provider $0.50 per note for analytics services requested by a third-party dealer involved in the offering. Morgan Stanley & Co. specifically disclaims any liability relating to the analytics and makes no representations or warranties regarding their use or fitness.

Automatic Early Redemption Mechanics and Conditions

The notes incorporate an automatic early redemption feature that triggers if specific market conditions are met on the first determination date, scheduled for July 26, 2027. If the closing level of each of the three underliers is greater than or equal to its call threshold level on that date, the notes will be automatically redeemed for an early redemption payment of $1,300 per note on July 29, 2027. The call threshold level is set at 100% of the initial level for all three underliers, meaning each stock must close at or above its strike-date closing price for automatic redemption to occur.

Once the notes are automatically redeemed, no further payments will be made on the notes and the investment terminates. This early redemption feature effectively caps returns for investors if all three stocks perform adequately, but it also provides certainty regarding timing and payment amount if conditions are satisfied. The $1,300 redemption payment represents a 30% return on the original $1,000 stated principal amount if early redemption is triggered, regardless of the magnitude of stock price appreciation beyond the 100% threshold.

Maturity Payment Structure and Contingent Upside

If the notes have not been automatically redeemed prior to the maturity date of July 27, 2029, investors will receive a payment at maturity determined by the performance of the worst-performing underlier. The filing states that if the final level of each underlier is greater than its initial level on the final determination date of July 24, 2029, investors will receive the stated principal amount of $1,000 plus an upside payment. The upside payment is calculated as the stated principal amount multiplied by a 150% participation rate and the worst-performing underlier's percentage change from initial to final level.

Conversely, if the final level of any underlier is equal to or less than its initial level, investors will receive only the stated principal amount of $1,000 at maturity with no additional upside payment. Critically, under no circumstances will the payment at maturity be less than the stated principal amount, meaning principal is protected provided the notes are not early redeemed and Morgan Stanley does not default. This floor protection comes at the cost of forgoing current interest income; the notes will pay no interest during their three-year term.

Worst-Performing Underlier Risk Concentration

The filing explicitly warns that the value of the notes is based on the worst-performing underlier and that linking the notes to multiple underliers provides no asset diversification benefits. The disclosure states: "The fact that the notes are linked to more than one underlier does not provide any asset diversification benefits and instead means that poor performance by any underlier will adversely affect your return on the notes, regardless of the performance of the other underliers." This language underscores that investors bear concentrated downside risk if any single stock underperforms, even if the other two stocks appreciate significantly.

For example, if AMD stock declines 5% while Meta and Microsoft both appreciate 20% over the investment period, the worst-performing underlier would be AMD, and the upside payment would be calculated using AMD's negative percentage change. This structure effectively creates asymmetric risk where investors benefit only if all three stocks appreciate, or benefit partially if they appreciate but at differing rates. The worst-performer methodology diverges substantially from traditional diversified investment approaches and concentrates performance risk on the single weakest link in the basket.

Target Investor Profile and Suitability Constraints

Morgan Stanley's disclosure identifies the target investor for these notes as those concerned about principal risk and willing to forgo current income in exchange for principal repayment at maturity and the possibility of receiving early redemption or maturity payments exceeding the stated principal amount. This characterization suggests the notes are designed for conservative investors seeking capital preservation with limited upside exposure, rather than growth or income-focused investors. The requirement that notes be sold only to investors in fee-based advisory accounts further restricts the investor pool to sophisticated, advised participants.

The suitability framework emphasizes that these notes are not appropriate for investors seeking regular income, as the notes pay no interest. Additionally, investors must have sufficient time horizon and risk tolerance to accept the possibility that all three underliers could underperform their initial levels, resulting in a return equal only to the initial principal amount over three years. The fee-based advisory account requirement implies that investors will receive personalized advice regarding the appropriateness of this investment for their individual circumstances and financial objectives.

Key Dates and Determination Timeline

The investment timeline establishes several critical dates that investors must track. The strike date and pricing date are both set for July 24, 2026, establishing the baseline closing levels for each underlier against which all future performance is measured. The original issue date is July 29, 2026, marking when investors' capital becomes committed to the investment. The first determination date for early redemption is July 26, 2027, approximately one year after inception, on which Morgan Stanley will assess whether automatic redemption conditions have been satisfied.

If early redemption does not occur, the investment continues until the final determination date of July 24, 2029, when closing levels for all three underliers are assessed to determine the maturity payment amount. The maturity date itself is July 27, 2029, three business days after the final determination date, when investors receive their maturity payment. All determination dates are subject to postponement for non-trading days and certain market disruption events, meaning the actual assessment dates may shift if markets are closed or experience significant disruptions on scheduled determination dates.

Valuation Methodology and Pricing Model Inputs

The filing discloses that Morgan Stanley's estimate of the notes' value on the pricing date is determined using the company's own pricing and valuation models, market inputs, and assumptions relating to the underliers and instruments based on the underliers. The valuation incorporates volatility estimates and other factors including current and expected interest rates, as well as an interest rate related to Morgan Stanley's secondary market credit spread. This credit spread reflects the implied interest rate at which Morgan Stanley's conventional fixed-rate debt instruments trade in the market, serving as a proxy for the company's cost of funding.

The valuation process accounts for both the debt component of the notes and the performance-based component linked to the three underlier stocks. Because structured notes embed derivative exposures that require continuous hedging by the issuer, the valuation models must account for the costs and risks of maintaining those hedges throughout the note term. The estimated value of approximately $983.90 per note, versus the $1,000 issue price, reflects the total embedded costs including issuer profit margins, dealer compensation, and hedging expenses. This valuation methodology is proprietary to Morgan Stanley and is not disclosed in detail in the filing.

Credit Risk and Guarantee Structure

The notes' full and unconditional guarantee by Morgan Stanley represents a critical credit enhancement that distinguishes them from unsecured debt of Morgan Stanley Finance LLC alone. However, the guarantee does not eliminate credit risk; it merely elevates the promise-paying entity to Morgan Stanley rather than its special-purpose subsidiary. If Morgan Stanley experiences financial distress or defaults on its obligations, investors would be unsecured creditors competing for recovery with other unsecured creditors in a bankruptcy proceeding. The filing emphasizes that all payments on the notes are subject to Morgan Stanley's credit risk and that investors could lose some or all of their investment if Morgan Stanley defaults.

The notes are explicitly not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality. This distinction is important because deposit insurance does not apply to structured notes issued by broker-dealers or their finance subsidiaries. Investors have no access to the underlying reference assets themselves and hold no claim on AMD, Meta, or Microsoft stock or assets. The notes represent only an unsecured contractual obligation of Morgan Stanley to pay specified amounts contingent on market conditions relating to those three stocks.

Regulatory Classification and Distribution Restrictions

The preliminary pricing supplement is filed pursuant to Securities and Exchange Commission Rule 424(b)(2) under the Securities Act of 1933 and is part of registration statement numbers 333-293641 and 333-293641-01. The notes are issued as part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program, which provides a framework for issuing various structured investment products. The CUSIP for these notes is 61781GN23, and the ISIN is US61781GN233, providing identifiers for trading and settlement purposes. The notes will not be listed on any securities exchange and will trade, if at all, in the over-the-counter secondary market.

The notes are restricted in distribution to investors in fee-based advisory accounts, meaning they cannot be sold through traditional commission-based brokerage channels. This restriction aligns with Morgan Stanley's compensation structure for this offering, under which the agent does not receive a sales commission with respect to the notes. The involvement of third-party data analytics providers and the careful specification of who may receive structuring fees indicates that Morgan Stanley has structured the distribution to comply with regulatory and compliance requirements while maintaining specific compensation arrangements with dealers and advisors involved in the offering.